Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL)
Prof. Paolo Angeli was selected by the EASL Governing Board, with his appointment validated in April 2019 during EASL’s general assembly. Prof. Angeli will be supported by a senior editorial team composed of well recognized leaders in hepatology: Patrizia Burra, Vlad Ratziu, Bruno Sangro, Frank Tacke and Stefan Zeuzem. Prof. Angeli and his team started handling new submissions on July 1st 2019 and will take over the management of the Journal on January 1st 2020.
Paolo Angeli is full Professor of Internal Medicine and Chief of the Unit of Internal Medicine and Hepatology (UIMH) of the Department of Medicine (DIMED) at the University of Padova, Italy. Currently Chair of the EASL-Clif Steering Committee – a body which involves over 110 hospitals across Europe – Prof. Angeli has developed very close clinical, research and personal collaborations with hepatologists from many centres in Europe, the Americas and Asia. His main field of scientific interest is clinical hepatology, with a particular focus on cirrhosis, acute-on-chronic liver failure and liver transplantation. He has authored more than 250 peer-reviewed articles that have shaped the clinical management of patients with cirrhosis. In 2018 he was chair of the EASL Clinical Practice Guidelines on the management of patients with decompensated cirrhosis.
Prof. Angeli has served in the Journal of Hepatology’s Editorial team as Associate Editor for the last 8 years. Prof. Angeli succeeds Prof. Rajiv Jalan who has been the Editor-in-Chief of the Journal of Hepatology since 2014, during which time he has consolidated its position as the major journal in the field and increased its scientific and geopolitical outreach.
Commenting on his vision for the future of the Journal, Prof. Angeli said, “My aim is to continue building and disseminating science on the strong foundation of where the Journal of Hepatology stands today. We need to improve the interaction with patients, the general public and policymakers to improve the perception of liver diseases. I am ready from a personal, clinical, academic, editorial and geopolitical standpoint to lead the Journal into a new era of growth, innovation and excellence.”
“Prof Angeli is a recognised and respected leader in the field of advanced liver diseases, where he has led major studies that have improved the survival and quality of life of critically ill patients. We look forward to working with Prof. Angeli on the continual improvement of the Journal and the fulfilment of its mission to be “The Home of Liver Research”, said Prof. Philip Newsome, EASL’s Secretary General.
About the Journal of Hepatology
The Journal of Hepatology is a monthly, English language, peer-reviewed journal. First published in 1985 as the official journal of EASL, it provides an international forum for the publication of original articles, reviews and letters to the Editor describing basic laboratory, translational, and clinical investigations in hepatology. All articles undergo a rigorous peer review and are selected based on the originality of the findings, the superior quality of the work described, and the clarity of presentation.
This year the Journal of Hepatology achieved exceptional results with a 2018 impact factor of 18.95, the highest the Journal has achieved, and with more than 2,600,000 downloads in 2018, it is firmly established as one of the premier publications in the field of Gastroenterology and Hepatology. Last year 46% of submissions originated from Asia, 13% from the USA and 33% from Europe, indicating the truly international nature of the Journal.